Quoin Pharmaceuticals, Ltd.

Ownership Transactions Reported by 9 Insiders

Symbol
QNRX on Nasdaq
Location
23 Hata'as Street, Kfar Saba, Israel

Insiders trading volume in the past year

Quoin Pharmaceuticals, Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Myers Chief Executive Officer, Director $271K +$250K +1176% May 29, 2025
Denise Carter Chief Operating Officer, Director $271K +$250K +1180% May 29, 2025
Dennis Langer Director $129K +$129K +1608000% Oct 14, 2025
Gordon Dunn Chief Financial Officer $68K +$55K +424% Dec 23, 2024
Anthony James Culverwell Director $45.1K +$45K +31469% Aug 21, 2025
Natalie Leong Director Aug 21, 2025
Michael Sember Director May 29, 2025
Joseph Cooper Director May 29, 2025
Sally Bridget Lawlor Chief Financial Officer Dec 1, 2025

Recent Insider Transactions by Companies or Individuals for Quoin Pharmaceuticals, Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.